Granules India Ltd-$

Granules India Ltd-$

$GRANULESPharmaceuticalsNSEBSE

Granules India Ltd-$ (GRANULES) last traded at ₹845, a market capitalisation of ₹20,944 crore, on a P/E of 32.2. Over the past 52 weeks the stock has ranged between ₹456 and ₹910. Granules India Ltd-$ last reported results for the quarter ended Jun 2026, with sales of ₹1,477 crore and net profit of ₹180 crore. Figures are as of 25 Aug 2026 and are not real time.

Granules India Ltd-$ share price and key metrics

Current price
₹845
Market cap
₹20,944 cr
Stock P/E
32.2
Book value
₹205
ROE
13.8%
ROCE
15.5%
Dividend yield
0.20%
52w high / low
910/456

Metrics as of 25 Aug 2026. Not real time.

Granules India Ltd-$ quarterly results

In the quarter ended Jun 2026, sales were ₹1,477 cr, up 22.1% from ₹1,210 cr a year earlier. Net profit was ₹180 cr, up 59.3% year on year.

Granules India Ltd-$ consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9671,1381,1971,2101,2971,3881,4711,477
Expenses7639079459631,0191,0801,1191,138
Operating profit203230252247278308352339
OPM %21%20%21%20%21%22%24%23%
Other income3633-10-1-4252
Interest2627242429293321
Depreciation5357646972748280
Profit before tax128153198145176202262240
Tax %24%23%23%22%26%26%23%25%
Net profit97118152113131150202180
EPS (₹)4.014.856.274.645.386.198.137.26

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Granules India Ltd-$ annual results

Granules India Ltd-$ annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3,2383,7654,5124,5064,4825,3665,632
Operating profit8567279158589481,1881,277
OPM %26%19%20%19%21%22%23%
Net profit549413517405502595662
EPS (₹)22.1816.6421.3416.7220.6824.0126.96

TTM is the trailing twelve months to the most recent quarter.

Granules India Ltd-$ growth and returns

Compounded Sales Growth
10 Years
15%
5 Years
11%
3 Years
6%
TTM
25%
Compounded Profit Growth
10 Years
17%
5 Years
2%
3 Years
5%
TTM
36%
Stock Price CAGR
10 Years
21%
5 Years
21%
3 Years
43%
1 Year
86%
Return on Equity
10 Years
17%
5 Years
15%
3 Years
14%
Last Year
14%

Granules India Ltd-$ shareholding pattern

Promoters held 38.01% at Jun 2026, down from 38.82% at Jun 2025. FIIs 17.50% and DIIs 16.11%.

Granules India Ltd-$ shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters38.87%38.85%38.83%38.82%38.81%38.81%38.02%38.01%
FIIs19.49%15.87%15.14%13.24%14.09%13.55%15.31%17.50%
DIIs14.85%19.57%22.45%23.52%17.91%17.47%17.01%16.11%
Public26.80%25.71%23.56%24.41%29.17%30.15%29.67%28.36%
No. of shareholders2,02,1981,77,5541,69,8021,69,7001,65,5421,63,1841,60,2861,69,422

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Granules India Ltd-$ corporate filings

  • Change in Senior Management Personnel (SMP) of the CompanyCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Granules India Limited has announced the internal transfer of Mr. Sanjay Kumar, currently…

    Read the full analysis
  • Outcome of 35th Annual General Meeting of the CompanyAGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Granules India Limited has successfully concluded its 35th Annual General Meeting held on…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of IndiaInsider Trading / SASThigh impact
    Filing PDF

    Cruxal's analysis: Granules India Ltd. has disclosed that Life Insurance Corporation of India (LIC) has…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Granules India Ltd-$

Cruxal reads every Granules India Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.